Use Of Emt Gene Signatures In Cancer Drug Discovery, Diagnostics, And Treatment

Abstract

The present invention provides diagnostic methods for assessing the EMT status of tumor cells, and for predicting the effectiveness of treatment of a cancer patient with an EGFR or IGF-1R kinase inhibitor, utilizing an EMT gene signature index score. The present invention further provides methods for treating patients with cancer that incorporate these methods.


Claims

Download Citation


Sign in to the Lens

Feedback